Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cancer Pain × Dosage Forms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Substance-Related Disorders 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Opioid-Induced Constipation 1 Neoplasms 1 Lymphoma, Follicular 1 Lymphoma 1 Low Anterior Resection Syndrome 1 Kidney Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Cancer Pain 1 Breast Neoplasms 1 Agnosia 1 Acromegaly 1

Interventions

Morphine 10 Methadone 6 Acetaminophen 5 Oxycodone 4 Lidocaine 4 Fentanyl 4 Ethanol 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Acupuncture Therapy 3 Transcranial Direct Current Stimulation 2 Surveys and Questionnaires 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 oxycodone naloxone combination 1 nabiximols 1 incobotulinumtoxinA 1 Water 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Tapentadol 1 Sugars 1 Standard of Care 1 Ropivacaine 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05216328 2024-11-22

OMAMA

Amsterdam UMC, location VUmc

Phase 4 Recruiting

Cancer Pain, Opioid-Induced Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡